According to the degree of correlation adherens junction, IL-17 signaling pathway, melanoma, non-small cell lung cancer, relaxin signaling pathway and microRNAs in cancer, etc. However, although these pathways contribute to both LUAD and LUSC, the strength of the contribution is still indistinguishable, and therefore, further analysis and validation (immunofluorescence, etc.)are needed. This evidence concerns the gene IL17A and non-small cell lung carcinoma.